Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | April Roundup
Liquid Biopsy (LBx) continued to develop through April, featuring new clinical and research collaborations as well as trial launches and study results.
May 11, 2022
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | April Roundup
Liquid Biopsy (LBx) continued to develop through April, featuring new clinical and research collaborations as well as trial launches and study results.
May 11, 2022
Liquid Biopsy
DeciBio Q&A
Clinical Diagnostics
Cancer Detection in Dogs: OncoK9 Liquid Biopsy and the CANDiD Study Q&A with Daniel Grosu of PetDx
A few of our experts talk with Daniel S. Grosu, MD, MBA, Founder, President and CEO of PetDx, a liquid biopsy company that intends to revolutionize how we detect cancer in man’s best friend — canines.
May 3, 2022
DeciBio Q&A
Clinical Diagnostics
Cancer Detection in Dogs: OncoK9 Liquid Biopsy and the CANDiD Study Q&A with Daniel Grosu of PetDx
A few of our experts talk with Daniel S. Grosu, MD, MBA, Founder, President and CEO of PetDx, a liquid biopsy company that intends to revolutionize how we detect cancer in man’s best friend — canines.
May 3, 2022
Precision Medicine
Liquid Biopsy
Immuno-Oncology
Blog Article
Pharma & Biotech
Multiplex Tissue Analysis and Digital Pathology - A summary of AACR 2022 Findings
Our biomarker intelligence team summarizes critical insights on multiplex tissue analysis and digital pathology from AACR 2022. Discover key activity and key players involved in the latest clinical research.
April 21, 2022
Blog Article
Pharma & Biotech
Multiplex Tissue Analysis and Digital Pathology - A summary of AACR 2022 Findings
Our biomarker intelligence team summarizes critical insights on multiplex tissue analysis and digital pathology from AACR 2022. Discover key activity and key players involved in the latest clinical research.
April 21, 2022
Immuno-Oncology
Proteomics Market
Diagnostics Market
Life Science Market Research
Clinical Diagnostics
DeciBio Q&A
Research Tools
The Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch Q&A with Omid Farokhzad
We interviewed Omid Farokhzad about the Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch.
April 20, 2022
DeciBio Q&A
Research Tools
The Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch Q&A with Omid Farokhzad
We interviewed Omid Farokhzad about the Future of Proteomics: Seer’s Origins & the Proteograph’s Commercial Launch.
April 20, 2022
Clinical Diagnostics
Proteomics Market
.png)
Newsletter Update
Pharma & Biotech
Digital Health | Q1 2022 Update
From ViVE 2022 to exciting regulatory approvals, product launches, partnerships, and acquisitions for the digital health space, Q1 2022 is off to an eventful start.
April 5, 2022
Newsletter Update
Pharma & Biotech
Digital Health | Q1 2022 Update
From ViVE 2022 to exciting regulatory approvals, product launches, partnerships, and acquisitions for the digital health space, Q1 2022 is off to an eventful start.
April 5, 2022
Digital Health
Health Technology Market
Medical Devices
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | March Roundup
Liquid Biopsy (LBx) continues to develop with each month, featuring more clinical trial updates and platform launches as well as new LBx approvals worldwide.
April 4, 2022
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | March Roundup
Liquid Biopsy (LBx) continues to develop with each month, featuring more clinical trial updates and platform launches as well as new LBx approvals worldwide.
April 4, 2022
Liquid Biopsy
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved